Interleukin-7 receptor blockade suppresses adaptive and innate inflammatory responses in experimental colitis

Journal of Inflammation (United Kingdom)

Volumn 9, Issue , 2012, Pages

  Willis, Cynthia R ^a   Seamons, Audrey ^b   Maxwell, Joe ^a   Treuting, Piper M ^b   Nelson, Laurel ^a   Chen, Guang ^a   Phelps, Susan ^b   Smith, Carole L ^a   Brabb, Thea ^b   Iritani, Brian M ^b,c   Maggio Price, Lillian ^b  

^a AMGEN INC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Colitis; Helicobacter bilis; IL 7R; Mdr1a mice; Rag2 mice

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G2B; INTERLEUKIN 7 RECEPTOR; RECOMBINANT INTERLEUKIN 7;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; COLITIS; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; HELICOBACTER BILIS; HELICOBACTER INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE; LOW DRUG DOSE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT DURATION;

BACTERIA (MICROORGANISMS); HELICOBACTER BILIS; MUS;

EID: 84867301807     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-39     Document Type: Article

References (26)

1. New pathogenic paradigms in inflammatory bowel disease. Di Sabatino A, Biancheri P, Rovedatti L, Macdonald TT, Corazza GR, Inflamm Bowel Dis 2012 18 368 371 10.1002/ibd.21735 21538717
2. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Ma A, Koka R, Burkett P, Annu Rev Immunol 2006 24 657 679 10.1146/annurev.immunol.24. 021605.090727 16551262
3. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. Watanabe M, Watanabe N, Iwao Y, Ogata H, Kanai T, Ueno Y, Tsuchiya M, Ishii H, Aiso S, Habu S, Hibi T, J Clin Immunol 1997 17 282 292 10.1023/A:1027322631036 9258767 (Pubitemid 27356133)
4. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease. Kader HA, Tchernev VT, Satyaraj E, Lejnine S, Kotler G, Kingsmore SF, Patel DD, Am J Gastroenterol 2005 100 414 423 10.1111/j.1572-0241. 2005.40819.x 15667502 (Pubitemid 40314529)
5. Gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis. Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K, et al. J Gastroenterol Hepatol 2006 21 32 40 10.1111/j.1440-1746.2005.04148.x 16706809
6. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, et al. Nat Genet 2011 43 246 252 10.1038/ng.764 21297633
7. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. Watanabe M, Ueno Y, Yajima T, Okamoto S, Hayashi T, Yamazaki M, Iwao Y, Ishii H, Habu S, Uehira M, et al. J Exp Med 1998 187 389 402 10.1084/jem.187.3.389 9449719 (Pubitemid 28080068)
8. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. von Freeden-Jeffry U, Davidson N, Wiler R, Fort M, Burdach S, Murray R, J Immunol 1998 161 5673 5680 9820548 (Pubitemid 28519135)
9. IL-7 exacerbates chronic colitis with expansion of memory IL-7Rhigh CD4+ mucosal T cells in mice. Okada E, Yamazaki M, Tanabe M, Takeuchi T, Nanno M, Oshima S, Okamoto R, Tsuchiya K, Nakamura T, Kanai T, et al. Am J Physiol Gastrointest Liver Physiol 2005 288 745 G754 10.1152/ajpgi.00276.2004 15550560 (Pubitemid 40388186)
10. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. Yamazaki M, Yajima T, Tanabe M, Fukui K, Okada E, Okamoto R, Oshima S, Nakamura T, Kanai T, Uehira M, et al. J Immunol 2003 171 1556 1563 12874249 (Pubitemid 36900091)
11. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL, Am J Pathol 2002 160 739 751 10.1016/S0002-9440(10) 64894-8 11839595 (Pubitemid 34160352)
12. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL, Am J Pathol 2005 166 1793 1806 10.1016/S0002-9440(10)62489-3 15920164 (Pubitemid 40734402)
13. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L, Am J Physiol Gastrointest Liver Physiol 2001 281 764 G778 11518689
14. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Goverman J, J Exp Med 2000 192 871 880 10993917
15. IL-7 Is essential for the development and the persistence of chronic colitis. Totsuka T, Kanai T, Nemoto Y, Makita S, Okamoto R, Tsuchiya K, Watanabe M, J Immunol 2007 178 4737 4748 17404253 (Pubitemid 46595254)
16. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis. Nemoto Y, Kanai T, Makita S, Okamoto R, Totsuka T, Takeda K, Watanabe M, Gastroenterology 2007 132 176 189 10.1053/j.gastro. 2006.10.035 17241870 (Pubitemid 46108748)
17. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. Fry TJ, Mackall CL, J Immunol 2005 174 6571 6576 15905493 (Pubitemid 40705615)
18. Interleukin-7: from bench to clinic. Fry TJ, Mackall CL, Blood 2002 99 3892 3904 10.1182/blood.V99.11.3892 12010786 (Pubitemid 35332024)
19. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Vivien L, Benoist C, Mathis D, Int Immunol 2001 13 763 768 10.1093/intimm/13.6.763 11369703 (Pubitemid 32514700)
20. Upregulated IL-7 receptor (alpha) expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis. Shinohara T, Nemoto Y, Kanai T, Kameyama K, Okamoto R, Tsuchiya K, Nakamura T, Totsuka T, Ikuta K, Watanabe M, J Immunol 2011 186 2623 2632 10.4049/jimmunol.1000057 21217010
21. Dendritic cells in intestinal immune regulation. Coombes JL, Powrie F, Nat Rev Immunol 2008 8 435 446 10.1038/nri2335 18500229 (Pubitemid 351733420)
22. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, et al. Nat Immunol 2009 10 149 157 19136960
23. A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. Fort MM, Leach MW, Rennick DM, J Immunol 1998 161 3256 3261 9759840
24. Regulation of chronic colitis in athymic nu/nu (nude) mice. Laroux FS, Norris HH, Houghton J, Pavlick KP, Bharwani S, Merrill DM, Fuseler J, Chervenak R, Grisham MB, Int Immunol 2004 16 77 89 10.1093/intimm/dxh006 14688063 (Pubitemid 38054629)
25. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. van Roon JA, Verweij MC, Wijk MW, Jacobs KM, Bijlsma JW, Lafeber FP, Arthritis Rheum 2005 52 1700 1710 10.1002/art.21045 15934068 (Pubitemid 40852878)
26. A critical role for IL-7R signaling in the development of Helicobacter felis-induced gastritis in mice. Ohana M, Okazaki K, Oshima C, Andra's D, Nishi T, Uchida K, Uose S, Nakase H, Matsushima Y, Chiba T, Gastroenterology 2001 121 329 336 10.1053/gast.2001.26289 11487542 (Pubitemid 32729380)